Field dossier · from the corpus
Tolerability
0predicted collisions
Where this field is predicted to collide
No open collisions on this field in the current run.
Most cited work
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines